Biotechnology
The Biotechnology industry has a total of 590 stocks, with a combined market cap of $1.25 trillion and total revenue of $115.82 billion.
Market Cap
1.25T
Revenue
115.82B
Profits
-36B
PE Ratio
n/a
Profit Margin
-31.08%
Dividend Yield
0.04%
590 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 128.85B | -0.34% | 517,923 | 12.59B |
| 2 | MRNA | Moderna, Inc. | 84.53B | -5.89% | 10,509,372 | 2.23B |
| 3 | REGN | Regeneron Pharmaceuticals, Inc. | 76.34B | 2.41% | 361,284 | 15.53B |
| 4 | ARGX | argenx SE | 50.67B | -0.67% | 154,629 | 5.32B |
| 5 | RVMD | Revolution Medicines, Inc. | 41.44B | 1.90% | 1,098,949 | - |
| 6 | ONC | BeOne Medicines AG | 39.94B | -0.89% | 123,203 | 6.13B |
| 7 | RPRX | Royalty Pharma plc | 33.17B | 1.32% | 1,081,274 | 2.54B |
| 8 | ALNY | Alnylam Pharmaceuticals, Inc. | 30.41B | -2.32% | 550,896 | 4.80B |
| 9 | ROIV | Roivant Sciences Ltd. | 25.05B | -2.13% | 2,708,146 | 7.53M |
| 10 | BNTX | BioNTech SE | 24.27B | -0.35% | 789,081 | 3.03B |
| 11 | INCY | Incyte Corporation | 22.74B | -0.52% | 655,546 | 5.82B |
| 12 | GMAB | Genmab A/S | 22.13B | 1.13% | 2,293,162 | 4.13B |
| 13 | INSM | Insmed Incorporated | 21.51B | -2.09% | 939,604 | 1.14B |
| 14 | EXEL | Exelixis, Inc. | 14.95B | 0.82% | 1,600,788 | 2.44B |
| 15 | ASND | Ascendis Pharma A/S | 14.90B | -1.03% | 266,795 | 1.20B |
| 16 | JAZZ | Jazz Pharmaceuticals plc | 14.13B | -0.31% | 433,843 | 4.60B |
| 17 | SMMT | Summit Therapeutics Inc. | 13.82B | -1.73% | 3,057,254 | - |
| 18 | CORT | Corcept Therapeutics Incorporated | 13.10B | -0.01% | 280,877 | 830.81M |
| 19 | BBIO | BridgeBio Pharma, Inc. | 12.83B | 0.46% | 1,075,155 | 713.07M |
| 20 | HALO | Halozyme Therapeutics, Inc. | 12.64B | 0.87% | 1,097,085 | 1.66B |
| 21 | TECH | Bio-Techne Corporation | 11.37B | 0.08% | 1,448,141 | 1.22B |
| 22 | PCVX | Vaxcyte, Inc. | 10.92B | -2.77% | 1,341,947 | - |
| 23 | MDGL | Madrigal Pharmaceuticals, Inc. | 10.87B | -0.29% | 352,989 | 1.28B |
| 24 | BMRN | BioMarin Pharmaceutical Inc. | 10.78B | 1.67% | 1,385,961 | 3.41B |
| 25 | IBRX | ImmunityBio, Inc. | 10.74B | -3.57% | 7,897,974 | 165.79M |
| 26 | KRYS | Krystal Biotech, Inc. | 9.85B | 0.31% | 92,168 | 440.48M |
| 27 | TWST | Twist Bioscience Corporation | 9.41B | -6.12% | 1,552,817 | 431.80M |
| 28 | PTGX | Protagonist Therapeutics, Inc. | 9.36B | 0.59% | 595,882 | 281.99M |
| 29 | KYMR | Kymera Therapeutics, Inc. | 9.24B | -1.10% | 291,137 | 105.00M |
| 30 | CYTK | Cytokinetics, Incorporated | 8.72B | -0.30% | 618,053 | 67.67M |
| 31 | AXSM | Axsome Therapeutics, Inc. | 8.69B | -1.43% | 351,583 | 776.57M |
| 32 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.59B | -3.08% | 511,175 | 669.50M |
| 33 | CAI | Caris Life Sciences, Inc. | 8.31B | -0.98% | 2,664,491 | 989.61M |
| 34 | SYRE | Spyre Therapeutics, Inc. | 8.03B | 0.32% | 425,247 | - |
| 35 | TGTX | TG Therapeutics, Inc. | 7.83B | -0.24% | 411,687 | 799.54M |
| 36 | ABVX | ABIVAX Société Anonyme | 7.56B | -1.91% | 418,462 | 5.33M |
| 37 | IONS | Ionis Pharmaceuticals, Inc. | 7.27B | -3.33% | 847,169 | 874.09M |
| 38 | PRAX | Praxis Precision Medicines, Inc. | 7.05B | -2.83% | 184,357 | 7.46M |
| 39 | IOVA | Iovance Biotherapeutics, Inc. | 6.60B | -0.27% | 6,828,839 | 324.97M |
| 40 | BLTE | Belite Bio, Inc | 6.38B | 2.60% | 191,499 | - |
| 41 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.20B | -0.86% | 230,993 | 239.92M |
| 42 | KOD | Kodiak Sciences Inc. | 6.15B | -1.86% | 1,002,375 | - |
| 43 | LGND | Ligand Pharmaceuticals Incorporated | 6.14B | 1.99% | 86,976 | 290.54M |
| 44 | IMVT | Immunovant, Inc. | 5.94B | -5.64% | 959,794 | - |
| 45 | CGON | CG Oncology, Inc. | 5.60B | -1.05% | 194,392 | 6.23M |
| 46 | MIRM | Mirum Pharmaceuticals, Inc. | 5.59B | 0.18% | 716,344 | 618.07M |
| 47 | ERAS | Erasca, Inc. | 5.43B | -3.18% | 2,001,649 | - |
| 48 | ORKA | Oruka Therapeutics, Inc. | 5.29B | -2.70% | 311,315 | - |
| 49 | PTCT | PTC Therapeutics, Inc. | 5.28B | -2.16% | 293,977 | 1.01B |
| 50 | COGT | Cogent Biosciences, Inc. | 5.18B | -3.65% | 1,251,059 | - |
| 51 | SRRK | Scholar Rock Holding Corporation | 5.11B | -0.60% | 451,590 | - |
| 52 | MANE | Veradermics, Incorporated | 5.06B | -7.55% | 593,119 | - |
| 53 | CRSP | CRISPR Therapeutics AG | 5.00B | -3.24% | 642,839 | 13.39M |
| 54 | TVTX | Travere Therapeutics, Inc. | 4.96B | 0.97% | 595,642 | 591.33M |
| 55 | DFTX | Definium Therapeutics, Inc. | 4.73B | -4.63% | 1,159,646 | - |
| 56 | DNTH | Dianthus Therapeutics, Inc. | 4.56B | -1.06% | 186,112 | 1.90M |
| 57 | EWTX | Edgewise Therapeutics, Inc. | 4.19B | -1.33% | 1,128,035 | - |
| 58 | TNGX | Tango Therapeutics, Inc. | 4.11B | 2.27% | 1,939,663 | 53.81M |
| 59 | ABCL | AbCellera Biologics Inc. | 4.10B | 0.76% | 3,795,667 | 66.17M |
| 60 | RLAY | Relay Therapeutics, Inc. | 3.91B | -0.17% | 1,416,792 | 10.35M |
| 61 | TLX | Telix Pharmaceuticals Limited | 3.89B | 0.71% | 191,192 | 890.79M |
| 62 | PBLS | Parabilis Medicines, Inc. | 3.52B | 3.77% | 906,350 | 148.00K |
| 63 | IDYA | IDEAYA Biosciences, Inc. | 3.48B | -0.19% | 257,579 | 234.13M |
| 64 | LEGN | Legend Biotech Corporation | 3.46B | -4.14% | 1,159,305 | 1.27B |
| 65 | XENE | Xenon Pharmaceuticals Inc. | 3.46B | -2.03% | 372,952 | 7.50M |
| 66 | ACAD | Acadia Pharmaceuticals Inc. | 3.36B | -1.42% | 551,975 | 1.14B |
| 67 | ARQT | Arcutis Biotherapeutics, Inc. | 3.31B | -0.94% | 862,902 | 463.98M |
| 68 | VKTX | Viking Therapeutics, Inc. | 3.30B | -0.84% | 1,722,269 | - |
| 69 | TARS | Tarsus Pharmaceuticals, Inc. | 3.26B | 1.63% | 526,005 | 606.33M |
| 70 | CELC | Celcuity Inc. | 3.21B | -3.50% | 543,910 | - |
| 71 | RCUS | Arcus Biosciences, Inc. | 3.11B | 0.16% | 701,373 | 117.00M |
| 72 | DNLI | Denali Therapeutics Inc. | 3.04B | -2.37% | 691,724 | 3.60M |
| 73 | ELVN | Enliven Therapeutics, Inc. | 2.98B | -0.73% | 360,046 | - |
| 74 | DYN | Dyne Therapeutics, Inc. | 2.96B | -4.90% | 1,372,887 | - |
| 75 | ZLAB | Zai Lab Limited | 2.79B | -0.50% | 341,465 | 449.61M |
| 76 | PGEN | Precigen, Inc. | 2.75B | -1.54% | 1,416,513 | 85.72M |
| 77 | NAMS | NewAmsterdam Pharma Company N.V. | 2.54B | -1.32% | 518,032 | 7.12M |
| 78 | BEAM | Beam Therapeutics Inc. | 2.54B | -0.97% | 801,694 | 156.04M |
| 79 | MBX | MBX Biosciences, Inc. | 2.53B | -1.26% | 152,957 | - |
| 80 | SLS | SELLAS Life Sciences Group, Inc. | 2.42B | 2.83% | 3,114,697 | - |
| 81 | IRON | Disc Medicine, Inc. | 2.34B | -1.95% | 364,212 | - |
| 82 | NRIX | Nurix Therapeutics, Inc. | 2.31B | -0.47% | 828,616 | 36.77M |
| 83 | ADMA | ADMA Biologics, Inc. | 2.30B | -0.97% | 791,295 | 512.28M |
| 84 | CLDX | Celldex Therapeutics, Inc. | 2.29B | -2.24% | 285,772 | 158.00K |
| 85 | HRMY | Harmony Biosciences Holdings, Inc. | 2.26B | -3.45% | 765,892 | 959.90M |
| 86 | AUPH | Aurinia Pharmaceuticals Inc. | 2.21B | -0.18% | 316,463 | 311.51M |
| 87 | IMNM | Immunome, Inc. | 2.19B | -1.43% | 491,202 | 4.02M |
| 88 | PHVS | Pharvaris N.V. | 2.16B | -1.00% | 383,017 | - |
| 89 | RXRX | Recursion Pharmaceuticals, Inc. | 2.15B | -8.14% | 20,152,636 | 54.86M |
| 90 | VRDN | Viridian Therapeutics, Inc. | 2.08B | -1.61% | 1,218,421 | 71.13M |
| 91 | VCEL | Vericel Corporation | 2.07B | 1.05% | 258,777 | 306.30M |
| 92 | NVAX | Novavax, Inc. | 2.06B | -2.20% | 6,763,928 | 413.80M |
| 93 | ADRX | ADARx Pharmaceuticals, Inc. | 2.04B | 2.31% | 200,973 | 6.13M |
| 94 | VERA | Vera Therapeutics, Inc. | 2.02B | -6.33% | 644,697 | - |
| 95 | FTRE | Fortrea Holdings Inc. | 2.00B | 0.74% | 532,984 | 2.68B |
| 96 | MLYS | Mineralys Therapeutics, Inc. | 1.97B | -4.79% | 496,504 | - |
| 97 | VIR | Vir Biotechnology, Inc. | 1.92B | -3.12% | 516,122 | 303.23M |
| 98 | PVLA | Palvella Therapeutics, Inc. | 1.92B | -4.09% | 136,178 | - |
| 99 | LKFT | Lakefront Biotherapeutics NV | 1.90B | -0.72% | 153,072 | 1.13B |
| 100 | MESO | Mesoblast Limited | 1.87B | 0.42% | 94,928 | 120.25M |
| 101 | TRVI | Trevi Therapeutics, Inc. | 1.85B | -1.48% | 807,527 | - |
| 102 | AGIO | Agios Pharmaceuticals, Inc. | 1.85B | -2.70% | 361,380 | 98.34M |
| 103 | XNCR | Xencor, Inc. | 1.85B | 0.85% | 413,685 | 104.97M |
| 104 | SRPT | Sarepta Therapeutics, Inc. | 1.85B | -2.07% | 1,626,792 | 1.97B |
| 105 | URGN | UroGen Pharma Ltd. | 1.84B | 1.95% | 308,483 | 188.73M |
| 106 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.83B | -5.04% | 635,096 | 208.78M |
| 107 | ZYME | Zymeworks Inc. | 1.80B | -1.55% | 207,654 | 37.13M |
| 108 | GENB | Generate Biomedicines, Inc. | 1.79B | -3.00% | 417,476 | 26.48M |
| 109 | NTLA | Intellia Therapeutics, Inc. | 1.78B | -2.72% | 2,764,588 | 59.51M |
| 110 | BHVN | Biohaven Ltd. | 1.77B | -2.77% | 919,615 | - |
| 111 | SEPN | Septerna, Inc. | 1.75B | -2.28% | 113,420 | 98.88M |
| 112 | ZBIO | Zenas BioPharma, Inc. | 1.73B | -2.68% | 94,639 | 1.00M |
| 113 | GPCR | Structure Therapeutics Inc. | 1.73B | -5.21% | 885,918 | - |
| 114 | NUVB | Nuvation Bio Inc. | 1.72B | -1.80% | 1,652,694 | 169.90M |
| 115 | OCUL | Ocular Therapeutix, Inc. | 1.69B | 2.06% | 2,403,402 | 52.06M |
| 116 | BRVE | Braveheart Bio, Inc. | 1.68B | 2.75% | 92,150 | - |
| 117 | ABSI | Absci Corporation | 1.65B | -5.41% | 2,004,236 | 1.56M |
| 118 | STOK | Stoke Therapeutics, Inc. | 1.57B | -1.82% | 174,691 | 27.59M |
| 119 | MAZE | Maze Therapeutics, Inc. | 1.56B | 3.39% | 1,077,176 | 20.00M |
| 120 | KRSA | Korsana Biosciences, Inc. | 1.55B | 0.24% | 51,314 | - |
| 121 | INVA | Innoviva, Inc. | 1.55B | 0.90% | 238,604 | 440.00M |
| 122 | IMCR | Immunocore Holdings plc | 1.50B | -1.05% | 121,401 | 430.78M |
| 123 | QURE | uniQure N.V. | 1.50B | -4.52% | 784,805 | 18.67M |
| 124 | RARE | Ultragenyx Pharmaceutical Inc. | 1.49B | -2.10% | 1,405,452 | 717.00M |
| 125 | KLRA | Kailera Therapeutics, Inc. | 1.49B | -1.21% | 769,274 | - |
| 126 | SNDX | Syndax Pharmaceuticals, Inc. | 1.47B | -3.12% | 652,496 | 252.25M |
| 127 | AAPG | Ascentage Pharma Group International | 1.47B | 4.81% | 4,261 | 94.61M |
| 128 | RAPP | Rapport Therapeutics, Inc. | 1.46B | -0.78% | 63,452 | 20.00M |
| 129 | COAG | Hemab Therapeutics Holdings, Inc. | 1.43B | -3.24% | 140,961 | - |
| 130 | OMER | Omeros Corporation | 1.42B | -1.16% | 697,630 | 38.42M |
| 131 | GHRS | GH Research PLC | 1.38B | -4.59% | 106,580 | - |
| 132 | ANAB | AnaptysBio, Inc. | 1.38B | 0.22% | 216,824 | 106.09M |
| 133 | NKTR | Nektar Therapeutics | 1.37B | -2.73% | 586,937 | 54.59M |
| 134 | TSHA | Taysha Gene Therapies, Inc. | 1.36B | -7.02% | 1,193,573 | 5.49M |
| 135 | TYRA | Tyra Biosciences, Inc. | 1.34B | -1.91% | 171,896 | - |
| 136 | KARD | Kardigan, Inc. | 1.34B | -2.04% | 164,399 | - |
| 137 | INBX | Inhibrx Biosciences, Inc. | 1.32B | -5.27% | 80,661 | 1.30M |
| 138 | DRTS | Alpha Tau Medical Ltd. | 1.31B | -1.49% | 182,798 | - |
| 139 | TRAX | First Tracks Biotherapeutics, Inc. | 1.27B | 11.99% | 6,167,302 | - |
| 140 | DMRA | Damora Therapeutics, Inc. | 1.24B | -4.60% | 175,871 | - |
| 141 | SVRA | Savara Inc. | 1.24B | -1.02% | 790,867 | - |
| 142 | REPL | Replimune Group, Inc. | 1.23B | -2.61% | 745,311 | - |
| 143 | ORIC | ORIC Pharmaceuticals, Inc. | 1.22B | -2.00% | 494,016 | - |
| 144 | VOR | Vor Biopharma Inc. | 1.19B | 1.11% | 589,107 | - |
| 145 | NBTX | Nanobiotix S.A. | 1.18B | -2.51% | 149,347 | 13.15M |
| 146 | BCAX | Bicara Therapeutics Inc. | 1.14B | -1.34% | 387,551 | - |
| 147 | LBRX | LB Pharmaceuticals Inc | 1.13B | -6.05% | 206,739 | - |
| 148 | JANX | Janux Therapeutics, Inc. | 1.11B | -0.98% | 411,682 | 24.00M |
| 149 | AVLN | Avalyn Pharma Inc. | 1.11B | -2.68% | 58,230 | - |
| 150 | LTGO | Latigo Biotherapeutics, Inc. | 1.06B | - | 68,272 | - |
| 151 | MNKD | MannKind Corporation | 1.00B | -5.02% | 2,251,658 | 393.63M |
| 152 | MGTX | MeiraGTx Holdings plc | 999.81M | -2.62% | 269,537 | 397.50M |
| 153 | IMTX | Immatics N.V. | 996.47M | -1.88% | 546,739 | 47.65M |
| 154 | AKTS | Aktis Oncology, Inc. | 975.57M | -3.36% | 138,256 | 10.06M |
| 155 | CGEM | Cullinan Therapeutics, Inc. | 962.75M | -3.67% | 184,285 | - |
| 156 | ANRO | Alto Neuroscience, Inc. | 942.99M | -1.40% | 178,533 | - |
| 157 | SPTX | Seaport Therapeutics, Inc. | 934.11M | -3.86% | 55,534 | - |
| 158 | MLTX | MoonLake Immunotherapeutics | 929.37M | 0.92% | 556,338 | - |
| 159 | KURA | Kura Oncology, Inc. | 926.08M | -1.79% | 792,561 | 77.23M |
| 160 | ANL | Adlai Nortye Group Ltd. | 914.45M | -9.09% | 330,134 | 18.06M |
| 161 | ALMS | Alumis Inc. | 912.52M | -1.54% | 936,037 | 7.40M |
| 162 | RIGL | Rigel Pharmaceuticals, Inc. | 912.32M | -0.49% | 88,267 | 276.79M |
| 163 | GLUE | Monte Rosa Therapeutics, Inc. | 897.50M | 2.14% | 925,037 | 28.73M |
| 164 | JBIO | Jade Biosciences, Inc. | 888.46M | -2.92% | 1,012,900 | - |
| 165 | ODTX | Odyssey Therapeutics, Inc. | 874.99M | -3.89% | 134,999 | 99.00K |
| 166 | SLBT | SL Science Holding Limited | 872.51M | 1.32% | 20,681 | 3.27M |
| 167 | CRVS | Corvus Pharmaceuticals, Inc. | 843.73M | -4.66% | 393,223 | - |
| 168 | SGP | SpyGlass Pharma, Inc. | 831.52M | -0.24% | 44,066 | - |
| 169 | ABUS | Arbutus Biopharma Corporation | 820.08M | -1.78% | 1,366,418 | 181.72M |
| 170 | HELP | Helus Pharma Inc. | 819.74M | -4.92% | 1,645,755 | - |
| 171 | ARDX | Ardelyx, Inc. | 807.37M | -1.22% | 2,394,355 | 450.89M |
| 172 | AVBP | ArriVent BioPharma, Inc. | 804.70M | -2.45% | 901,859 | - |
| 173 | OBX | Obsidian Therapeutics, Inc. | 793.16M | -1.23% | 341,475 | - |
| 174 | GERN | Geron Corporation | 787.03M | - | 2,558,680 | 204.56M |
| 175 | DNA | Ginkgo Bioworks Holdings, Inc. | 784.51M | -10.38% | 2,104,665 | 132.42M |
| 176 | SANA | Sana Biotechnology, Inc. | 784.32M | -6.09% | 1,640,481 | - |
| 177 | APMD | Apnimed, Inc. | 776.00M | 0.65% | 212,579 | 115.12M |
| 178 | IMMX | Immix Biopharma, Inc. | 767.68M | -2.11% | 625,307 | - |
| 179 | IVA | Inventiva S.A. | 766.16M | -1.27% | 2,498,306 | 2.81M |
| 180 | ANNX | Annexon, Inc. | 756.42M | -0.75% | 1,024,955 | - |
| 181 | CADL | Candel Therapeutics, Inc. | 753.71M | -0.91% | 389,832 | - |
| 182 | VSTM | Verastem, Inc. | 737.64M | -2.80% | 2,362,176 | 87.53M |
| 183 | GYRE | Gyre Therapeutics, Inc. | 735.34M | -1.49% | 31,037 | 109.82M |
| 184 | ACHV | Achieve Life Sciences, Inc. | 731.12M | -4.12% | 585,382 | - |
| 185 | SLDB | Solid Biosciences Inc. | 721.63M | -2.04% | 305,290 | - |
| 186 | LXRX | Lexicon Pharmaceuticals, Inc. | 718.60M | -3.87% | 1,115,699 | 41.47M |
| 187 | FDMT | 4D Molecular Therapeutics, Inc. | 718.17M | -2.48% | 520,935 | 92.01M |
| 188 | AVTX | Avalo Therapeutics, Inc. | 708.45M | -3.22% | 263,434 | 59.00K |
| 189 | MDXG | MiMedx Group, Inc. | 702.57M | 3.21% | 289,547 | 355.17M |
| 190 | OABI | OmniAb, Inc. | 695.69M | -0.10% | 756,017 | 38.46M |
| 191 | DSGN | Design Therapeutics, Inc. | 692.78M | -4.98% | 136,430 | - |
| 192 | AURA | Aura Biosciences, Inc. | 684.97M | 0.99% | 315,798 | - |
| 193 | ATTO | Attovia Therapeutics, Inc. | 682.71M | -7.74% | 148,027 | 1.80M |
| 194 | PHAR | Pharming Group N.V. | 678.38M | -1.94% | 5,094 | 366.48M |
| 195 | ZVRA | Zevra Therapeutics, Inc. | 674.01M | -0.35% | 249,612 | 136.07M |
| 196 | OLMA | Olema Pharmaceuticals, Inc. | 650.98M | -4.86% | 598,117 | - |
| 197 | PRME | Prime Medicine, Inc. | 649.35M | -8.52% | 2,370,401 | 4.07M |
| 198 | WVE | Wave Life Sciences, Inc. | 648.29M | -4.91% | 1,426,944 | 65.37M |
| 199 | NVCT | Nuvectis Pharma, Inc. | 641.53M | -6.77% | 90,155 | - |
| 200 | SGMT | Sagimet Biosciences Inc. | 626.83M | -1.01% | 823,750 | - |
| 201 | CLYM | Climb Bio, Inc. | 620.89M | -1.73% | 482,542 | - |
| 202 | CBIO | Crescent Biopharma, Inc. | 615.05M | -3.62% | 79,346 | 11.88M |
| 203 | STTK | Shattuck Labs, Inc. | 605.69M | 1.09% | 498,133 | 1.00M |
| 204 | FTH | Faeth Therapeutics, Inc. | 601.05M | -10.64% | 198,726 | - |
| 205 | ETRA | Electra Therapeutics, Inc. | 584.99M | 3.10% | 127,584 | - |
| 206 | SLN | Silence Therapeutics plc | 584.03M | -1.62% | 331,665 | 615.00K |
| 207 | CRMD | CorMedix Inc. | 583.02M | 1.36% | 1,018,679 | 462.25M |
| 208 | VALN | Valneva SE | 567.67M | 1.38% | 6,970 | 163.30M |
| 209 | PHAT | Phathom Pharmaceuticals, Inc. | 562.76M | -2.28% | 349,144 | 239.66M |
| 210 | BLSM | BlossomHill Therapeutics, Inc. | 557.19M | 0.29% | 57,594 | - |
| 211 | DBVT | DBV Technologies S.A. | 547.54M | -2.45% | 231,599 | 5.04M |
| 212 | DRUG | Bright Minds Biosciences Inc. | 539.52M | 1.22% | 84,891 | - |
| 213 | PBYI | Puma Biotechnology, Inc. | 537.36M | 1.17% | 160,575 | 231.24M |
| 214 | ACRS | Aclaris Therapeutics, Inc. | 537.28M | -4.70% | 1,370,241 | 8.22M |
| 215 | CTMX | CytomX Therapeutics, Inc. | 529.50M | -5.45% | 1,492,336 | 18.30M |
| 216 | RGNX | REGENXBIO Inc. | 528.77M | -0.74% | 1,274,787 | 174.48M |
| 217 | MNPR | Monopar Therapeutics Inc. | 519.59M | -1.96% | 90,544 | - |
| 218 | RZLT | Rezolute, Inc. | 507.18M | -0.72% | 548,898 | - |
| 219 | PROK | ProKidney Corp. | 501.86M | -4.60% | 362,393 | 818.00K |
| 220 | ALT | Altimmune, Inc. | 500.88M | -1.34% | 1,459,560 | 31.00K |
| 221 | NGNE | Neurogene Inc. | 494.38M | -6.42% | 237,504 | 925.00K |
| 222 | ARVN | Arvinas, Inc. | 494.32M | -1.05% | 233,780 | 316.70M |
| 223 | OCS | Oculis Holding AG | 488.30M | -5.16% | 228,578 | 1.45M |
| 224 | EPRX | Eupraxia Pharmaceuticals Inc. | 485.74M | -1.07% | 182,633 | - |
| 225 | MPLT | MapLight Therapeutics, Inc. | 485.18M | -1.13% | 354,902 | - |
| 226 | ALLO | Allogene Therapeutics, Inc. | 483.69M | -4.11% | 2,698,722 | 4.64M |
| 227 | OVID | Ovid Therapeutics Inc. | 472.62M | -1.63% | 582,617 | 1.58M |
| 228 | AUTL | Autolus Therapeutics plc | 467.12M | -3.04% | 737,748 | 117.39M |
| 229 | ASMB | Assembly Biosciences, Inc. | 466.26M | -2.68% | 92,724 | 74.85M |
| 230 | ENTX | Entera Bio Ltd. | 462.29M | 0.38% | 218,990 | 42.00K |
| 231 | AGMB | AgomAb Therapeutics NV | 455.54M | 1.87% | 41,033 | - |
| 232 | YDES | YD Bio Limited | 451.90M | -5.20% | 127,936 | 1.24M |
| 233 | DMAC | DiaMedica Therapeutics Inc. | 442.73M | -1.44% | 134,689 | - |
| 234 | TECX | Tectonic Therapeutic, Inc. | 436.34M | -4.33% | 58,924 | - |
| 235 | CAPR | Capricor Therapeutics, Inc. | 436.04M | -4.21% | 1,023,775 | 11.13M |
| 236 | PRTA | Prothena Corporation plc | 434.31M | -4.30% | 324,718 | 54.53M |
| 237 | EDIT | Editas Medicine, Inc. | 423.88M | -4.83% | 878,175 | 47.01M |
| 238 | SPRY | ARS Pharmaceuticals, Inc. | 415.69M | -1.18% | 833,204 | 116.93M |
| 239 | AVIR | Atea Pharmaceuticals, Inc. | 408.24M | -1.17% | 90,305 | - |
| 240 | GALT | Galectin Therapeutics Inc. | 396.34M | -0.25% | 67,920 | - |
| 241 | PRLD | Prelude Therapeutics Incorporated | 394.47M | -1.54% | 110,727 | 22.42M |
| 242 | IRD | Opus Genetics, Inc. | 391.85M | 1.29% | 846,949 | 9.86M |
| 243 | EIKN | Eikon Therapeutics, Inc. | 390.53M | -3.48% | 129,986 | - |
| 244 | KYTX | Kyverna Therapeutics, Inc. | 388.38M | -1.72% | 244,185 | - |
| 245 | ZURA | Zura Bio Limited | 385.23M | 0.50% | 1,347,982 | - |
| 246 | VTVT | vTv Therapeutics Inc. | 385.17M | -0.58% | 8,282 | 36.84M |
| 247 | SCTX | Scribe Therapeutics Inc. | 384.41M | -4.09% | 280,928 | 33.30M |
| 248 | TRXB | TRex Bio, Inc. | 380.95M | 1.07% | 92,306 | - |
| 249 | CCCC | C4 Therapeutics, Inc. | 378.30M | -2.69% | 958,783 | 35.04M |
| 250 | FENC | Fennec Pharmaceuticals Inc. | 374.52M | -0.28% | 60,595 | 59.22M |
| 251 | RLMD | Relmada Therapeutics, Inc. | 372.81M | 3.10% | 742,992 | - |
| 252 | ARCT | Arcturus Therapeutics Holdings Inc. | 363.53M | -6.91% | 273,665 | 29.37M |
| 253 | ENTA | Enanta Pharmaceuticals, Inc. | 356.49M | -2.08% | 67,832 | 65.26M |
| 254 | OBIO | Orchestra BioMed Holdings, Inc. | 351.92M | -1.60% | 117,981 | 31.98M |
| 255 | TTRX | Turn Therapeutics Inc. | 343.75M | -3.83% | 20,271 | - |
| 256 | CTNM | Contineum Therapeutics, Inc. | 336.52M | -33.15% | 6,757,404 | - |
| 257 | AGEN | Agenus Inc. | 336.30M | -2.61% | 377,950 | 132.69M |
| 258 | ARTV | Artiva Biotherapeutics, Inc. | 331.23M | -2.38% | 153,752 | 251.00K |
| 259 | IKT | Inhibikase Therapeutics, Inc. | 330.47M | -7.87% | 490,306 | 1.00 |
| 260 | INDP | Indaptus Therapeutics, Inc. | 325.11M | -2.79% | 297,984 | - |
| 261 | OCGN | Ocugen, Inc. | 324.12M | 0.03% | 2,207,869 | 4.58M |
| 262 | BNTC | Benitec Biopharma Inc. | 319.00M | 3.10% | 116,017 | - |
| 263 | CABA | Cabaletta Bio, Inc. | 311.96M | -4.66% | 2,943,889 | - |
| 264 | EYPT | EyePoint, Inc. | 287.09M | -2.06% | 767,257 | 2.79M |
| 265 | CUVL | Clinuvel Pharmaceuticals Limited | 286.83M | 1.25% | 10,341 | 65.05M |
| 266 | FULC | Fulcrum Therapeutics, Inc. | 285.35M | -0.80% | 439,941 | 80.00M |
| 267 | SRZN | Surrozen, Inc. | 284.49M | -18.47% | 1,125,713 | 11.51M |
| 268 | XFOR | X4 Pharmaceuticals, Inc. | 282.57M | -2.06% | 274,099 | 15.85M |
| 269 | ABEO | Abeona Therapeutics Inc. | 281.92M | -0.20% | 381,415 | 25.52M |
| 270 | PALI | Palisade Bio, Inc. | 277.96M | 3.57% | 1,167,075 | 500.00K |
| 271 | VNDA | Vanda Pharmaceuticals Inc. | 273.59M | -0.98% | 315,437 | 215.72M |
| 272 | RCKT | Rocket Pharmaceuticals, Inc. | 272.24M | -3.13% | 1,487,398 | - |
| 273 | LRMR | Larimar Therapeutics, Inc. | 267.74M | -3.93% | 592,904 | - |
| 274 | NAUT | Nautilus Biotechnology, Inc. | 265.96M | -7.11% | 10,325,041 | 190.00K |
| 275 | BCYC | Bicycle Therapeutics plc | 265.27M | -2.57% | 169,396 | 61.21M |
| 276 | IPSC | Century Therapeutics, Inc. | 263.46M | -1.02% | 267,677 | 109.16M |
| 277 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 263.37M | -0.76% | 135,271 | - |
| 278 | QTTB | Q32 Bio Inc. | 260.48M | 4.92% | 486,570 | 53.74M |
| 279 | VCRE | Vicore Pharma Holding AB (publ) | 260.43M | 2.78% | 39,054 | 412.09K |
| 280 | GLSI | Greenwich LifeSciences, Inc. | 260.39M | 7.32% | 107,710 | - |
| 281 | SABS | SAB Biotherapeutics, Inc. | 259.31M | -4.36% | 218,266 | 114.70K |
| 282 | FATE | Fate Therapeutics, Inc. | 257.61M | -1.38% | 392,151 | 6.49M |
| 283 | LXEO | Lexeo Therapeutics, Inc. | 254.33M | -4.02% | 597,275 | - |
| 284 | IMRX | Immuneering Corporation | 250.38M | -1.78% | 396,390 | - |
| 285 | VOGX | Vogenx, Inc. | 247.93M | -4.95% | 81,243 | - |
| 286 | ACIU | AC Immune SA | 243.60M | -2.00% | 110,934 | 21.67M |
| 287 | ZNTL | Zentalis Pharmaceuticals, Inc. | 241.89M | -3.22% | 401,323 | 26.87M |
| 288 | PYXS | Pyxis Oncology, Inc. | 239.51M | -1.23% | 343,043 | 11.04M |
| 289 | LCTX | Lineage Cell Therapeutics, Inc. | 238.57M | -5.10% | 1,520,474 | 13.08M |
| 290 | PRQR | ProQR Therapeutics N.V. | 238.50M | 3.68% | 1,108,936 | 21.05M |
| 291 | IFRX | InflaRx N.V. | 237.26M | 0.63% | 289,290 | -11.54K |
| 292 | MGNX | MacroGenics, Inc. | 235.69M | -1.07% | 125,027 | 175.14M |
| 293 | SLGL | Sol-Gel Technologies Ltd. | 235.07M | 0.04% | 20,140 | 1.80M |
| 294 | KROS | Keros Therapeutics, Inc. | 233.66M | -1.38% | 128,710 | 15.01M |
| 295 | CAMP | Camp4 Therapeutics Corporation | 233.44M | -1.33% | 18,361 | 4.22M |
| 296 | UPB | Upstream Bio, Inc. | 232.50M | -9.68% | 508,951 | 3.16M |
| 297 | ALEC | Alector, Inc. | 230.01M | -0.96% | 1,126,747 | 13.86M |
| 298 | PLX | Protalix BioTherapeutics, Inc. | 224.79M | 0.36% | 498,142 | 80.62M |
| 299 | EVMN | Evommune, Inc. | 219.93M | -3.04% | 209,919 | 10.00M |
| 300 | STRO | Sutro Biopharma, Inc. | 216.47M | -8.51% | 138,582 | 45.70M |
| 301 | SION | Sionna Therapeutics, Inc. | 212.50M | -4.08% | 364,567 | - |
| 302 | RNAC | Cartesian Therapeutics, Inc. | 212.39M | -0.50% | 73,806 | 1.48M |
| 303 | LYEL | Lyell Immunopharma, Inc. | 205.11M | -3.90% | 51,226 | 27.00K |
| 304 | TRDA | Entrada Therapeutics, Inc. | 198.67M | -2.82% | 113,062 | 4.69M |
| 305 | IVVD | Invivyd, Inc. | 198.02M | -6.85% | 2,426,853 | 58.37M |
| 306 | ELDN | Eledon Pharmaceuticals, Inc. | 197.66M | -2.02% | 167,282 | - |
| 307 | CGEN | Compugen Ltd. | 197.50M | -2.11% | 61,037 | 74.00M |
| 308 | WHWK | Whitehawk Therapeutics, Inc. | 194.69M | -2.98% | 136,306 | 7.15M |
| 309 | ACOG | Alpha Cognition Inc. | 193.67M | -1.62% | 33,739 | 15.26M |
| 310 | NGEN | NervGen Pharma Corp. | 188.16M | 1.16% | 159,013 | - |
| 311 | YARW | Yarrow Bioscience, Inc. | 183.20M | -0.10% | 54,660 | - |
| 312 | ADAG | Adagene Inc. | 181.96M | -1.81% | 162,070 | 9.29M |
| 313 | DTIL | Precision BioSciences, Inc. | 179.96M | -2.98% | 172,509 | 45.06M |
| 314 | CUE | Cue Biopharma, Inc. | 179.65M | -10.59% | 149,209 | 37.66M |
| 315 | ORMP | Oramed Pharmaceuticals Inc. | 175.96M | -2.31% | 44,587 | 2.00M |
| 316 | PEPG | PepGen Inc. | 172.80M | -4.77% | 226,091 | - |
| 317 | ALXO | ALX Oncology Holdings Inc. | 168.70M | -2.40% | 466,205 | - |
| 318 | CNTN | Canton Strategic Holdings, Inc. | 168.13M | - | 368,096 | 1.50M |
| 319 | CMPX | Compass Therapeutics, Inc. | 167.55M | -6.30% | 3,208,301 | 850.00K |
| 320 | VRXA | Veraxa Biotech AG | 164.03M | -7.94% | 141,871 | 29.54K |
| 321 | TARA | Protara Therapeutics, Inc. | 162.51M | -0.18% | 569,820 | - |
| 322 | ANTX | AN2 Therapeutics, Inc. | 162.27M | -2.27% | 158,986 | - |
| 323 | MDWD | MediWound Ltd. | 162.02M | 0.08% | 40,314 | 11.86M |
| 324 | CHRS | Coherus Oncology, Inc. | 160.68M | -2.80% | 728,678 | 50.94M |
| 325 | NKTX | Nkarta, Inc. | 157.93M | -2.00% | 413,323 | - |
| 326 | NBP | NovaBridge Biosciences | 154.28M | -4.66% | 193,317 | - |
| 327 | MSLE | Satellos Bioscience Inc. | 154.15M | -3.20% | 54,585 | - |
| 328 | MENS | Jyong Biotech Ltd. | 152.18M | -2.38% | 16,029 | - |
| 329 | ABOS | Acumen Pharmaceuticals, Inc. | 147.17M | -4.91% | 195,208 | - |
| 330 | CDXS | Codexis, Inc. | 146.74M | -4.96% | 424,238 | 77.68M |
| 331 | MOLN | Molecular Partners AG | 143.19M | -3.25% | 2,367 | 856.30K |
| 332 | KRRO | Korro Bio, Inc. | 142.03M | -5.07% | 69,967 | 2.38M |
| 333 | VYGR | Voyager Therapeutics, Inc. | 141.41M | -6.33% | 626,189 | 34.46M |
| 334 | AVXL | Anavex Life Sciences Corp. | 141.36M | 2.35% | 599,577 | - |
| 335 | OTLK | Outlook Therapeutics, Inc. | 141.18M | -3.17% | 2,008,025 | -1.16M |
| 336 | RNA | Atrium Therapeutics, Inc. | 140.95M | -1.90% | 44,192 | 35.84M |
| 337 | TLSA | Tiziana Life Sciences Ltd | 139.65M | -9.24% | 512,078 | - |
| 338 | NERV | Minerva Neurosciences, Inc. | 137.99M | -9.12% | 56,164 | - |
| 339 | ARMP | Armata Pharmaceuticals, Inc. | 133.48M | -1.10% | 37,073 | 5.54M |
| 340 | NRXP | NRx Pharmaceuticals, Inc. | 124.60M | 1.05% | 319,623 | 3.39M |
| 341 | HURA | TuHURA Biosciences, Inc. | 124.27M | -0.51% | 139,692 | - |
| 342 | SPRB | Spruce Biosciences, Inc. | 124.21M | -1.88% | 66,983 | 697.00K |
| 343 | TNYA | Tenaya Therapeutics, Inc. | 124.13M | -4.60% | 2,011,342 | 1.34M |
| 344 | IPHA | Innate Pharma S.A. | 123.95M | -9.26% | 30,660 | 11.21M |
| 345 | KZIA | Kazia Therapeutics Limited | 122.65M | 0.22% | 27,230 | 1.27M |
| 346 | SEER | Seer, Inc. | 119.60M | -1.37% | 90,581 | 14.22M |
| 347 | FHTX | Foghorn Therapeutics Inc. | 118.18M | -0.50% | 422,199 | 36.74M |
| 348 | TNXP | Tonix Pharmaceuticals Holding Corp. | 115.94M | -7.40% | 665,499 | 29.10M |
| 349 | INO | Inovio Pharmaceuticals, Inc. | 115.29M | -3.04% | 1,893,242 | 65.34K |
| 350 | COYA | Coya Therapeutics, Inc. | 114.71M | -1.21% | 75,682 | 8.02M |
| 351 | LENZ | LENZ Therapeutics, Inc. | 114.53M | - | 440,870 | 21.48M |
| 352 | GNLX | Genelux Corporation | 113.82M | -0.78% | 52,388 | 8.00K |
| 353 | ENGN | enGene Therapeutics Inc. | 113.59M | -2.02% | 352,999 | - |
| 354 | MIST | Milestone Pharmaceuticals Inc. | 113.42M | 5.22% | 899,149 | 2.34M |
| 355 | CBUS | Cibus, Inc. | 113.11M | -4.52% | 63,194 | 4.35M |
| 356 | UNCY | Unicycive Therapeutics, Inc. | 111.98M | -2.19% | 390,095 | - |
| 357 | HUMA | Humacyte, Inc. | 110.09M | -2.22% | 14,010,141 | 2.12M |
| 358 | IMUX | Immunic, Inc. | 109.43M | -2.08% | 96,963 | - |
| 359 | VANI | Vivani Medical, Inc. | 107.79M | -4.40% | 136,178 | - |
| 360 | PMVP | PMV Pharmaceuticals, Inc. | 107.23M | -6.58% | 230,216 | - |
| 361 | TENX | Tenax Therapeutics, Inc. | 106.54M | -0.53% | 532,294 | - |
| 362 | PDSB | PDS Biotechnology Corporation | 106.54M | 6.52% | 13,087,478 | - |
| 363 | RANI | Rani Therapeutics Holdings, Inc. | 105.54M | -5.24% | 352,280 | 4.88M |
| 364 | CNXU | Conexeu Sciences Inc. | 105.21M | -4.11% | 323,194 | - |
| 365 | PYPD | PolyPid Ltd. | 103.18M | 0.20% | 48,667 | - |
| 366 | BDTX | Black Diamond Therapeutics, Inc. | 102.84M | -2.19% | 266,318 | 70.00M |
| 367 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 101.74M | -2.23% | 775,115 | - |
| 368 | TVGN | Tevogen Inc. | 101.34M | -5.01% | 2,363 | - |
| 369 | BMEA | Biomea Fusion, Inc. | 100.03M | -2.82% | 549,607 | - |
| 370 | ANIX | Anixa Biosciences, Inc. | 99.60M | -1.21% | 66,893 | - |
| 371 | PLYX | Polaryx Therapeutics, Inc. | 99.25M | -0.44% | 15,561 | - |
| 372 | OKUR | OnKure Therapeutics, Inc. | 98.81M | 1.24% | 99,863 | - |
| 373 | AARD | Aardvark Therapeutics, Inc. | 97.50M | -6.41% | 34,331 | - |
| 374 | ATRA | Atara Biotherapeutics, Inc. | 94.86M | -0.32% | 13,594 | 6.19M |
| 375 | RTSN | Retension Pharmaceuticals, Inc. | 93.86M | 6.98% | 95,541 | - |
| 376 | EQ | Equillium, Inc. | 91.31M | 2.13% | 244,027 | 4.39M |
| 377 | RLYB | Rallybio Corporation | 89.91M | -0.53% | 2,820 | 646.00K |
| 378 | ICCC | ImmuCell Corporation | 87.19M | -2.04% | 6,507 | 30.68M |
| 379 | PMN | ProMIS Neurosciences, Inc. | 85.51M | -0.78% | 18,387 | - |
| 380 | CLLS | Cellectis S.A. | 85.26M | -7.14% | 108,371 | 63.82M |
| 381 | NMRA | Neumora Therapeutics, Inc. | 84.67M | -5.28% | 714,637 | - |
| 382 | NRXS | NeurAxis, Inc. | 83.76M | -3.75% | 65,325 | 5.32M |
| 383 | CRDF | Cardiff Oncology, Inc. | 82.85M | -1.39% | 302,436 | 508.00K |
| 384 | TELO | Telomir Pharmaceuticals, Inc. | 82.45M | - | 64,740 | - |
| 385 | ACRV | Acrivon Therapeutics, Inc. | 81.64M | -0.26% | 112,061 | - |
| 386 | CGTX | Cognition Therapeutics, Inc. | 81.04M | -2.82% | 394,772 | - |
| 387 | HRTX | Heron Therapeutics, Inc. | 78.26M | 1.50% | 1,598,437 | 151.18M |
| 388 | PTHS | Pelthos Therapeutics Inc. | 78.02M | -0.59% | 40,642 | 43.30M |
| 389 | MNOV | MediciNova, Inc. | 76.79M | 2.63% | 97,238 | 920.48K |
| 390 | OKYO | OKYO Pharma Limited | 76.62M | 2.82% | 57,344 | - |
| 391 | NTRB | Nutriband Inc. | 75.85M | -6.17% | 10,428 | 1.62M |
| 392 | OSTX | OS Therapies Incorporated | 72.65M | -2.78% | 181,625 | - |
| 393 | MAIA | MAIA Biotechnology, Inc. | 71.47M | -3.69% | 146,008 | - |
| 394 | CING | Cingulate Inc. | 70.53M | -0.82% | 19,245 | - |
| 395 | FBIO | Fortress Biotech, Inc. | 70.20M | -1.41% | 80,764 | 68.47M |
| 396 | VRCA | Verrica Pharmaceuticals Inc. | 69.75M | -1.22% | 30,372 | 30.32M |
| 397 | GANX | Gain Therapeutics, Inc. | 69.61M | -2.74% | 229,061 | - |
| 398 | SPRO | Spero Therapeutics, Inc. | 69.01M | -1.25% | 351,849 | 47.00M |
| 399 | CSBR | Champions Oncology, Inc. | 68.90M | 2.27% | 7,081 | 60.66M |
| 400 | XBIT | XBiotech Inc. | 68.63M | -1.70% | 38,010 | - |
| 401 | NTHI | NeOnc Technologies Holdings, Inc. | 68.60M | -0.72% | 86,880 | 39.99K |
| 402 | RNTX | Rein Therapeutics Inc. | 67.03M | -2.14% | 104,714 | - |
| 403 | HYFT | MindWalk Holdings Corp. | 66.43M | -5.69% | 169,228 | 11.57M |
| 404 | PLRX | Pliant Therapeutics, Inc. | 61.31M | -2.93% | 233,959 | - |
| 405 | XLO | Xilio Therapeutics, Inc. | 60.47M | 1.55% | 6,689 | 64.09M |
| 406 | ACET | Adicet Bio, Inc. | 60.06M | -0.53% | 122,194 | - |
| 407 | ELOX | Eloxx Pharmaceuticals, Inc. | 59.05M | 6.48% | 23,069 | - |
| 408 | LONA | LeonaBio, Inc. | 58.98M | 8.87% | 371,179 | - |
| 409 | GUTS | Fractyl Health, Inc. | 58.63M | - | 94,075 | 3.00K |
| 410 | ALPS | Alps Group Inc | 58.37M | -5.19% | 13,627 | 3.74M |
| 411 | IBIO | iBio, Inc. | 58.08M | 3.70% | 341,022 | 100.00K |
| 412 | CNTB | Connect Biopharma Holdings Limited | 58.00M | 5.86% | 1,415,231 | 2.95M |
| 413 | ONCY | Oncolytics Biotech Inc. | 57.63M | -18.85% | 2,037,779 | - |
| 414 | BOLD | Boundless Bio, Inc. | 57.09M | -0.79% | 31,920 | - |
| 415 | RNXT | RenovoRx, Inc. | 56.86M | -1.56% | 192,385 | 1.98M |
| 416 | GOSS | Gossamer Bio, Inc. | 55.84M | -1.93% | 134,302 | 53.29M |
| 417 | HYPD | Hyperion DeFi, Inc. | 54.08M | 2.35% | 377,746 | 1.40M |
| 418 | CRBU | Caribou Biosciences, Inc. | 53.88M | 9.21% | 3,821,573 | 10.04M |
| 419 | ALDX | Aldeyra Therapeutics, Inc. | 53.82M | -2.63% | 989,111 | - |
| 420 | CLNN | Clene Inc. | 53.44M | -2.59% | 64,338 | 197.00K |
| 421 | INKT | MiNK Therapeutics, Inc. | 53.12M | -2.89% | 17,884 | - |
| 422 | KLRS | Kalaris Therapeutics, Inc. | 53.09M | -5.51% | 98,628 | - |
| 423 | ATHE | Alterity Therapeutics Limited | 52.27M | -6.58% | 17,838 | 2.50M |
| 424 | MREO | Mereo BioPharma Group plc | 51.74M | -7.40% | 1,123,567 | 500.00K |
| 425 | INMB | INmune Bio Inc. | 49.82M | -5.03% | 53,970 | 50.00K |
| 426 | ELTX | Elicio Therapeutics, Inc. | 49.67M | - | 129,252 | - |
| 427 | HOWL | Werewolf Therapeutics, Inc. | 49.09M | 3.10% | 661,781 | 21.00M |
| 428 | ANVS | Annovis Bio, Inc. | 49.00M | -4.96% | 381,490 | - |
| 429 | SER | Serina Therapeutics, Inc. | 48.90M | -3.75% | 112,815 | 130.00K |
| 430 | IMA | ImageneBio, Inc. | 48.07M | -0.12% | 15,815 | 800.00K |
| 431 | CELU | Celularity Inc. | 48.03M | -5.13% | 26,870 | 18.97M |
| 432 | DWTX | Dogwood Therapeutics, Inc. | 47.93M | 0.71% | 34,833 | - |
| 433 | EXOZ | eXoZymes, Inc. | 47.24M | -3.05% | 8,773 | -700.00 |
| 434 | APLM | Apollomics, Inc. | 47.00M | -0.47% | 1,400 | 8.84M |
| 435 | BSEM | BioStem Technologies, Inc. | 45.35M | -1.21% | 30,634 | 34.59M |
| 436 | TIL | Instil Bio, Inc. | 44.63M | -2.37% | 7,403 | - |
| 437 | GRCE | Grace Therapeutics, Inc. | 42.28M | -3.37% | 27,531 | - |
| 438 | VERU | Veru Inc. | 41.26M | -1.63% | 72,355 | 16.89M |
| 439 | EDSA | Edesa Biotech, Inc. | 40.67M | -14.25% | 55,934 | - |
| 440 | MGX | Metagenomi Therapeutics, Inc. | 38.34M | 1.50% | 138,005 | 13.56M |
| 441 | CRVO | CervoMed Inc. | 37.80M | -22.36% | 823,369 | 331.30K |
| 442 | FLNA | Filana Therapeutics, Inc. | 37.23M | -5.64% | 303,221 | - |
| 443 | LITS | Lite Strategy, Inc. | 37.10M | -3.94% | 235,728 | - |
| 444 | IBO | Impact BioMedical Inc. | 36.98M | 1.84% | 1,725 | 35.00K |
| 445 | ALGS | Aligos Therapeutics, Inc. | 34.03M | 2.06% | 54,840 | 31.52M |
| 446 | BCTX | BriaCell Therapeutics Corp. | 33.94M | -0.77% | 20,698 | - |
| 447 | NNVC | NanoViricides, Inc. | 33.18M | - | 101,620 | - |
| 448 | ATNM | Actinium Pharmaceuticals, Inc. | 33.01M | -4.55% | 75,151 | 35.09M |
| 449 | GRDX | GridAI Technologies Corp. | 32.86M | -6.64% | 26,958 | - |
| 450 | CVM | CEL-SCI Corporation | 32.01M | -6.19% | 321,263 | - |
| 451 | NXTC | NextCure, Inc. | 30.16M | -8.22% | 102,854 | - |
| 452 | IGC | IGC Pharma, Inc. | 29.08M | 0.50% | 214,152 | 1.11M |
| 453 | RNAZ | TransCode Therapeutics, Inc. | 28.36M | -9.95% | 24,478 | - |
| 454 | MCRB | Seres Therapeutics, Inc. | 27.32M | 0.37% | 37,153 | 1.88M |
| 455 | IMMP | Immutep Limited | 27.23M | -1.93% | 16,201 | 13.79M |
| 456 | CNTX | Context Therapeutics Inc. | 27.21M | -2.63% | 376,599 | - |
| 457 | KYNB | Kyntra Bio, Inc. | 25.39M | 2.62% | 21,529 | 4.62M |
| 458 | ABVC | ABVC BioPharma, Inc. | 25.28M | -2.50% | 13,398 | 797.92K |
| 459 | BYSI | BeyondSpring Inc. | 25.17M | 1.09% | 35,903 | 1.88M |
| 460 | EVAX | Evaxion A/S | 25.10M | -1.95% | 48,997 | 7.49M |
| 461 | ATOS | Atossa Therapeutics, Inc. | 23.85M | -2.05% | 74,408 | - |
| 462 | QNTM | Quantum BioPharma Ltd. | 23.05M | -3.06% | 131,461 | - |
| 463 | PLRZ | Polyrizon Ltd. | 22.19M | 1.63% | 5,686 | - |
| 464 | QNRX | Quoin Pharmaceuticals, Ltd. | 21.71M | 0.44% | 45,137 | - |
| 465 | ATYR | aTyr Pharma, Inc. | 21.51M | -10.93% | 1,646,343 | 190.00K |
| 466 | ICU | SeaStar Medical Holding Corporation | 20.39M | 7.34% | 94,096 | 1.71M |
| 467 | COCP | Cocrystal Pharma, Inc. | 20.23M | -1.87% | 7,269 | 330.00K |
| 468 | AKTX | Akari Therapeutics, Plc | 19.40M | -3.19% | 107,787 | - |
| 469 | PBM | Psyence Biomedical Ltd. | 18.46M | -2.62% | 20,764 | - |
| 470 | JSPR | Jasper Therapeutics, Inc. | 18.26M | -3.74% | 273,749 | - |
| 471 | NEUP | Neuphoria Therapeutics Inc. | 18.02M | -0.89% | 7,722 | 1.17M |
| 472 | NCEL | NewcelX Ltd. | 17.21M | -2.13% | 870 | - |
| 473 | TCRX | TScan Therapeutics, Inc. | 16.62M | 3.03% | 329,292 | 7.11M |
| 474 | MRKR | Marker Therapeutics, Inc. | 16.59M | 2.41% | 99,240 | 3.55M |
| 475 | KPRX | Kiora Pharmaceuticals, Inc. | 16.10M | -0.39% | 3,065 | 20.00K |
| 476 | ACTU | Actuate Therapeutics, Inc. | 15.85M | 8.14% | 246,612 | - |
| 477 | PTN | Palatin Technologies, Inc. | 15.42M | -0.58% | 16,047 | 13.19M |
| 478 | DYAI | Dyadic International, Inc. | 15.32M | -5.31% | 32,137 | 3.80M |
| 479 | BCDA | BioCardia, Inc. | 15.29M | -2.88% | 69,181 | 3.00K |
| 480 | KTTA | Pasithea Therapeutics Corp. | 15.12M | -3.23% | 63,954 | - |
| 481 | RADX | Radiopharm Theranostics Limited | 14.87M | -1.77% | 6,083 | 8.90M |
| 482 | DARE | Daré Bioscience, Inc. | 14.75M | -3.02% | 63,832 | 1.37M |
| 483 | HIND | Vyome Holdings, Inc. | 14.39M | -1.91% | 5,524 | 129.73K |
| 484 | ESLA | Estrella Immunopharma, Inc. | 14.35M | -19.51% | 788,272 | - |
| 485 | LPCN | Lipocine Inc. | 14.18M | - | 765,012 | 1.57M |
| 486 | ALLR | Allarity Therapeutics, Inc. | 14.16M | -10.10% | 368,182 | 345.00K |
| 487 | TVRD | Tvardi Therapeutics, Inc. | 14.14M | 2.91% | 205,581 | - |
| 488 | CNSY | Cerenome, Inc. | 13.96M | -4.66% | 45,615 | 4.20M |
| 489 | CLRB | Cellectar Biosciences, Inc. | 13.52M | -1.38% | 145,253 | - |
| 490 | CTXR | Citius Pharmaceuticals, Inc. | 13.44M | -2.00% | 94,297 | 7.11M |
| 491 | INAB | IN8bio, Inc. | 13.01M | -1.49% | 22,673 | - |
| 492 | PASG | Passage Bio, Inc. | 12.84M | 8.13% | 36,691 | - |
| 493 | AEON | AEON Biopharma, Inc. | 12.48M | -9.38% | 887,401 | - |
| 494 | TPST | Tempest Therapeutics, Inc. | 12.42M | -1.20% | 123,804 | - |
| 495 | GTBP | GT Biopharma, Inc. | 11.99M | -0.52% | 30,632 | - |
| 496 | KPTI | Karyopharm Therapeutics Inc. | 11.42M | -16.74% | 767,766 | 146.62M |
| 497 | BLRX | BioLineRx Ltd. | 11.25M | -3.43% | 26,617 | 1.39M |
| 498 | ENSC | Ensysce Biosciences, Inc. | 10.75M | 4.87% | 1,032,703 | 4.50M |
| 499 | PLUR | Pluri Inc. | 10.74M | -8.73% | 7,587 | 1.02M |
| 500 | PHIO | Phio Pharmaceuticals Corp. | 10.73M | -5.65% | 41,544 | - |